These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 34459865)

  • 1. Emerging Neuroimaging Biomarkers Across Disease Stage in Parkinson Disease: A Review.
    Mitchell T; Lehéricy S; Chiu SY; Strafella AP; Stoessl AJ; Vaillancourt DE
    JAMA Neurol; 2021 Oct; 78(10):1262-1272. PubMed ID: 34459865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Study of MRI Biomarkers in the Substantia Nigra to Discriminate Idiopathic Parkinson Disease.
    Pyatigorskaya N; Magnin B; Mongin M; Yahia-Cherif L; Valabregue R; Arnaldi D; Ewenczyk C; Poupon C; Vidailhet M; Lehéricy S
    AJNR Am J Neuroradiol; 2018 Aug; 39(8):1460-1467. PubMed ID: 29954816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroimaging in Parkinson's disease: focus on substantia nigra and nigro-striatal projection.
    Frosini D; Cosottini M; Volterrani D; Ceravolo R
    Curr Opin Neurol; 2017 Aug; 30(4):416-426. PubMed ID: 28537985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal Progression Markers of Parkinson's Disease: Current View on Structural Imaging.
    Yang J; Burciu RG; Vaillancourt DE
    Curr Neurol Neurosci Rep; 2018 Oct; 18(12):83. PubMed ID: 30280267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodal brain and retinal imaging of dopaminergic degeneration in Parkinson disease.
    Lee JY; Martin-Bastida A; Murueta-Goyena A; Gabilondo I; Cuenca N; Piccini P; Jeon B
    Nat Rev Neurol; 2022 Apr; 18(4):203-220. PubMed ID: 35177849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic Resonance Imaging Biomarkers to Assess Substantia Nigra Damage in Idiopathic Rapid Eye Movement Sleep Behavior Disorder.
    Pyatigorskaya N; Gaurav R; Arnaldi D; Leu-Semenescu S; Yahia-Cherif L; Valabregue R; Vidailhet M; Arnulf I; Lehéricy S
    Sleep; 2017 Nov; 40(11):. PubMed ID: 28958075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease.
    Meles SK; Oertel WH; Leenders KL
    Mol Med; 2021 Sep; 27(1):111. PubMed ID: 34530732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson's disease.
    Biondetti E; Santin MD; Valabrègue R; Mangone G; Gaurav R; Pyatigorskaya N; Hutchison M; Yahia-Cherif L; Villain N; Habert MO; Arnulf I; Leu-Semenescu S; Dodet P; Vila M; Corvol JC; Vidailhet M; Lehéricy S
    Brain; 2021 Nov; 144(10):3114-3125. PubMed ID: 33978742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroimaging Advances in Parkinson's Disease and Atypical Parkinsonian Syndromes.
    Saeed U; Lang AE; Masellis M
    Front Neurol; 2020; 11():572976. PubMed ID: 33178113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI T
    Lee H; Baek SY; Kim EJ; Huh GY; Lee JH; Cho H
    Neuroimage; 2020 May; 211():116625. PubMed ID: 32058001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substantia nigra locations of iron-content, free-water and mean diffusivity abnormalities in moderate stage Parkinson's disease.
    Arribarat G; Pasternak O; De Barros A; Galitzky M; Rascol O; Péran P
    Parkinsonism Relat Disord; 2019 Aug; 65():146-152. PubMed ID: 31182373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased free water in the substantia nigra in idiopathic REM sleep behaviour disorder.
    Zhou L; Li G; Zhang Y; Zhang M; Chen Z; Zhang L; Wang X; Zhang M; Ye G; Li Y; Chen S; Li B; Wei H; Liu J
    Brain; 2021 Jun; 144(5):1488-1497. PubMed ID: 33880500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substantia Nigra Free Water Increases Longitudinally in Parkinson Disease.
    Guttuso T; Bergsland N; Hagemeier J; Lichter DG; Pasternak O; Zivadinov R
    AJNR Am J Neuroradiol; 2018 Mar; 39(3):479-484. PubMed ID: 29419398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging in Movement Disorders.
    Maiti B; Perlmutter JS
    Continuum (Minneap Minn); 2023 Feb; 29(1):194-218. PubMed ID: 36795878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal Changes in Neuromelanin MRI Signal in Parkinson's Disease: A Progression Marker.
    Gaurav R; Yahia-Cherif L; Pyatigorskaya N; Mangone G; Biondetti E; Valabrègue R; Ewenczyk C; Hutchison RM; Cedarbaum JM; Corvol JC; Vidailhet M; Lehéricy S
    Mov Disord; 2021 Jul; 36(7):1592-1602. PubMed ID: 33751655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motor Progression and Nigrostriatal Neurodegeneration in Parkinson Disease.
    Furukawa K; Shima A; Kambe D; Nishida A; Wada I; Sakamaki H; Yoshimura K; Terada Y; Sakato Y; Mitsuhashi M; Sawamura M; Nakanishi E; Taruno Y; Yamakado H; Fushimi Y; Okada T; Nakamoto Y; Takahashi R; Sawamoto N
    Ann Neurol; 2022 Jul; 92(1):110-121. PubMed ID: 35428994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression marker of Parkinson's disease: a 4-year multi-site imaging study.
    Burciu RG; Ofori E; Archer DB; Wu SS; Pasternak O; McFarland NR; Okun MS; Vaillancourt DE
    Brain; 2017 Aug; 140(8):2183-2192. PubMed ID: 28899020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of Neuromelanin MR Imaging in Parkinson Disease.
    He N; Chen Y; LeWitt PA; Yan F; Haacke EM
    J Magn Reson Imaging; 2023 Feb; 57(2):337-352. PubMed ID: 36017746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substantia Nigra Neuromelanin as an Imaging Biomarker of Disease Progression in Parkinson's Disease.
    Fabbri M; Reimão S; Carvalho M; Nunes RG; Abreu D; Guedes LC; Bouça R; Lobo PP; Godinho C; Coelho M; Gonçalves NC; Rosa MM; Antonini A; Ferreira JJ
    J Parkinsons Dis; 2017; 7(3):491-501. PubMed ID: 28671143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substantia nigra neuromelanin magnetic resonance imaging in de novo Parkinson's disease patients.
    Reimão S; Pita Lobo P; Neutel D; Correia Guedes L; Coelho M; Rosa MM; Ferreira J; Abreu D; Gonçalves N; Morgado C; Nunes RG; Campos J; Ferreira JJ
    Eur J Neurol; 2015 Mar; 22(3):540-6. PubMed ID: 25534480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.